Correction: Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral

Genet Med. 2020 Mar;22(3):672. doi: 10.1038/s41436-019-0734-4.

Sari Lieberman^{1

2}, Ariela Tomer^{1

2}, Avi Ben-Chetrit^{1

3}, Oded Olsha⁴, Shalom Strano⁵, Rachel Beeri², Sivan Koka², Hila Fridman², Karen Djemal⁶, Itzhak Glick⁷, Todd Zalut^{8

9}, Shlomo Segev¹⁰, Miri Sklair^{11

12}, Bella Kaufman^{12

13}, Amnon Lahad^{1

14}, Aviad Raz¹⁵, Ephrat Levy-Lahad^{16

17}

¹ Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
² Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
³ Women's Health Center, Clalit Health Services, Jerusalem, Israel.
⁴ Surgical Department, Shaare Zedek Medical Center, Jerusalem, Israel.
⁵ The Comprehensive Breast Center, Shaare Zedek Medical Center, Jerusalem, Israel.
⁶ Terem Family Medical Center, Jerusalem, Israel.
⁷ Efrat Emergency Medical Center, Efrat, Israel.
⁸ Terem Clinic, Modi'in, Israel.
⁹ Department of Emergency Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.
¹⁰ Institute of Medical Screening, Chaim Sheba Medical Center, Tel Hashomer, Israel.
¹¹ Department of Radiology, Chaim Sheba Medical Center, Tel Hashomer, Israel.
¹² Sackler Faculty of Mediciine, Tel Aviv University, Tel Aviv, Israel.
¹³ Institute of Oncology, The Chaim Sheba Medical Center, Tel Hashomer, Israel.
¹⁴ Department of Family Medicine, Clalit Health Services, Jerusalem, Israel.
¹⁵ Department of Sociology and Anthropology, Ben-Gurion University of the Negev, Beer Sheva, Israel.
¹⁶ Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. lahad@szmc.org.il.
¹⁷ Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel. lahad@szmc.org.il.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.